Evidence map›Paper›PMID 39789219›Full record

ArticleNature cell biology2025

MDM2 functions as a timer reporting the length of mitosis.

Luke J Fulcher, Tomoaki Sobajima, Caleb Batley, Ian Gibbs-Seymour, Francis A Barr

Abstract read
In one paragraph

Article in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. The expanding MDM2 universe.Cell death and differentiation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. When the Clock Is Ticking: The Role of Mitotic Duration in Cell Fate Determination.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Permission to pass: on the role of p53 as a gatekeeper for aneuploidy.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luke J FulcherDepartment of Biochemistry, University of Oxford, Oxford, UK.
Tomoaki SobajimaDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-0753-5361
Caleb BatleyDepartment of Biochemistry, University of Oxford, Oxford, UK.
Ian Gibbs-SeymourDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-6904-2642
Francis A BarrDepartment of Biochemistry, University of Oxford, Oxford, UK. francis.barr@bioch.ox.ac.uk.ORCID 0000-0001-7518-253X

Funding

Cancer Research UK 24670Cancer Research UK DRCRPG-MAY23/100006Cancer Research UK (CRUK) C62538/A24670Cancer Research UK (CRUK) DRCRPG-May23
6 · The paper itself

Abstract

Delays in mitosis trigger p53-dependent arrest in G1 of the next cell cycle, thus preventing repeated cycles of chromosome instability and aneuploidy. Here we show that MDM2, the p53 ubiquitin ligase, is a key component of the timer mechanism triggering G1 arrest in response to prolonged mitosis. This timer function arises due to the attenuation of protein synthesis in mitosis. Because MDM2 has a short half-life and ongoing protein synthesis is therefore necessary to maintain its steady-state concentration, the amount of MDM2 gradually falls during mitosis but normally remains above a critical threshold for p53 regulation at the onset of G1. When mitosis is extended by prolonged spindle assembly checkpoint activation, the amount of MDM2 drops below this threshold, stabilizing p53. Subsequent p53-dependent p21 accumulation then channels G1 cells into a sustained cell-cycle arrest, whereas abrogation of the response in p53-deficient cells allows them to bypass this crucial defence mechanism.

Indexed as

MitosisProto-Oncogene Proteins c-mdm2AnimalsCyclin-Dependent Kinase Inhibitor p21G1 Phase Cell Cycle CheckpointsHumansSpindle ApparatusTime FactorsTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p21MDM2 protein, humanProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53

Identifiers

PMID39789219
PMCPMC11821534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.